66 related articles for article (PubMed ID: 21193310)
1. Tetrahydroquinoline derivatives as opioid receptor antagonists.
Zhang C; Westaway SM; Speake JD; Bishop MJ; Goetz AS; Carballo LH; Hu M; Epperly AH
Bioorg Med Chem Lett; 2011 Jan; 21(2):670-6. PubMed ID: 21193310
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1.
Takeuchi K; Holloway WG; McKinzie JH; Suter TM; Statnick MA; Surface PL; Emmerson PJ; Thomas EM; Siegel MG; Matt JE; Wolfe CN; Mitch CH
Bioorg Med Chem Lett; 2007 Oct; 17(19):5349-52. PubMed ID: 17720493
[TBL] [Abstract][Full Text] [Related]
3. Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
van Straten NC; van Berkel TH; Demont DR; Karstens WJ; Merkx R; Oosterom J; Schulz J; van Someren RG; Timmers CM; van Zandvoort PM
J Med Chem; 2005 Mar; 48(6):1697-700. PubMed ID: 15771412
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship (SAR) investigations of tetrahydroquinolines as BKCa agonists.
Gore VK; Ma VV; Yin R; Ligutti J; Immke D; Doherty EM; Norman MH
Bioorg Med Chem Lett; 2010 Jun; 20(12):3573-8. PubMed ID: 20493696
[TBL] [Abstract][Full Text] [Related]
5. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.
Geldenhuys WJ; Kuzenko SR; Simmons MA
J Med Chem; 2010 Nov; 53(22):8080-8. PubMed ID: 21047106
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
8. [6,7]-heterocycle-fused 14-hydroxymorphinan derivatives: design, synthesis, and opioid receptor activity.
Li F; Yin C; Chen J; Liu J; Xie X; Zhang A
ChemMedChem; 2009 Dec; 4(12):2103-10. PubMed ID: 19847845
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor antagonists with a 3-phenylquinazoline-2,4-dione/2-phenylisoquinoline-1,3-dione skeleton.
Nakagawa A; Uno S; Makishima M; Miyachi H; Hashimoto Y
Bioorg Med Chem; 2008 Jul; 16(14):7046-54. PubMed ID: 18586498
[TBL] [Abstract][Full Text] [Related]
12. Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.
Hayes ME; Breinlinger EC; Wallace GA; Grongsaard P; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
Bioorg Med Chem Lett; 2008 Apr; 18(7):2414-9. PubMed ID: 18337097
[TBL] [Abstract][Full Text] [Related]
13. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA
J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and SAR of sulfoxide substituted carboxyquinolines as NK3 receptor antagonists.
Xiong H; Kang J; Woods JM; McCauley JP; Koether GM; Albert JS; Hinkley L; Li Y; Gadient RA; Simpson TR
Bioorg Med Chem Lett; 2011 Mar; 21(6):1896-9. PubMed ID: 21320776
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.
Scott JD; Miller MW; Li SW; Lin SI; Vaccaro HA; Hong L; Mullins DE; Guzzi M; Weinstein J; Hodgson RA; Varty GB; Stamford AW; Chan TY; McKittrick BA; Greenlee WJ; Priestley T; Parker EM
Bioorg Med Chem Lett; 2009 Nov; 19(21):6018-22. PubMed ID: 19800231
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
Choi H; Murray TF; DeLander GE; Schmidt WK; Aldrich JV
J Med Chem; 1997 Aug; 40(17):2733-9. PubMed ID: 9276018
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists.
Barbay JK; Gong Y; Buntinx M; Li J; Claes C; Hornby PJ; Van Lommen G; Van Wauwe J; He W
Bioorg Med Chem Lett; 2008 Apr; 18(8):2544-8. PubMed ID: 18378452
[TBL] [Abstract][Full Text] [Related]
20. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
